These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29545968)

  • 1. Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma.
    Amhimmid Badr S; Waheeb Fahmi M; Mahmoud Nomir M; Mohammad El-Shishtawy M
    Cancer Biol Med; 2018 Feb; 15(1):52-60. PubMed ID: 29545968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
    Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
    Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.
    Shaker MK; Abdel Fattah HI; Sabbour GS; Montasser IF; Abdelhakam SM; El Hadidy E; Yousry R; El Dorry AK
    World J Hepatol; 2017 Mar; 9(9):469-476. PubMed ID: 28396717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
    Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
    Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
    Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
    Liu Z; Ling Q; Wang J; Xie H; Xu X; Zheng S
    Oncol Lett; 2013 Jul; 6(1):125-129. PubMed ID: 23946789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis.
    Ismail SA; El Saadany Sh; Ziada DH; Zakaria SS; Mayah WW; Elashry H; Arafa M; Elmashad N
    Asian Pac J Cancer Prev; 2017 Apr; 18(4):1105-1111. PubMed ID: 28547948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.
    Fouad SA; Mohamed NA; Fawzy MW; Moustafa DA
    Hepat Mon; 2015 Sep; 15(9):e30753. PubMed ID: 26500684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
    Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a role for serum aldo-keto reductase family 1 member B10 in early detection of hepatocellular carcinoma.
    Han C; Gao L; Bai H; Dou X
    Oncol Lett; 2018 Dec; 16(6):7123-7130. PubMed ID: 30546447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.